Lataa...
Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
PURPOSE: Combined treatment with alendronate and alfacalcidol is more useful to increase bone mineral density (BMD) than alendronate or alfacalcidol alone. A retrospective study was conducted to investigate the 3-year outcome of combined treatment with alendronate and alfacalcidol in patients with s...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132096/ https://ncbi.nlm.nih.gov/pubmed/21753888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S22167 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|